@conference{c623c82036314dda99516d41eb45bfc3,
title = "Prognostic factors in patients with WHO grade 3 gliomas: The Cleveland Clinic experience.",
author = "N. Hashemi-Sadraei and Bawa, \{H. S.\} and A. Satra and G. Rahmathulla and M. Patel and G. Stevens and Tekautz, \{T. M.\} and Rybicki, \{L. A.\} and Peereboom, \{D. M.\} and Suh, \{J. H.\} and R. Weil and Vogelbaum, \{M. A.\} and G. Barnett and Ahluwalia, \{M. S.\}",
note = "2053 Background: Anaplastic astrocytoma (AA), anaplastic oligodendroglioma (AO), and anaplastic oligoastrocytoma (AOA) are the major histological categories of WHO grade 3 gliomas. Most randomized trials pool both grades 3 or IV gliomas in their analysis. Consequently, there is limited data on specific prognostic factors for patients (pts) with grade 3 gliomas.; Journal of Clinical Oncology ; Conference date: 01-01-2020",
year = "2011",
month = may,
day = "20",
doi = "10.1200/JCO.2011.29.15\_SUPPL.2053",
language = "American English",
}